Zydus Lifesciences Board Meeting Scheduled for August 11, 2026 To Approve Q1 Financial Results
Zydus Lifesciences Limited has scheduled a meeting of its Board of Directors to review and approve the unaudited financial results for the quarter ending June 30, 2026.The company's board meeting is set for Tuesday, August 11, 2026, where the approval of these quarterly financial results will be one of the key agenda items.
In addition to the Board meeting announcement, Zydus provided an update regarding the trading window concerning insider trading regulations.
The trading window remains closed until Thursday, August 13, 2026. For all Directors and Designated Persons of the Company, the window for trading will open starting Friday, August 14, 2026.
ZYDUSLIFE Stock Price Movement
Shares of Zydus Lifesciences are rallying as of 1:14 PM today, climbing 1.85% in live trading to trade at ₹1164.90. The stock is currently seeing a strong performance, maintaining its movement within the intraday range established between a low of ₹1140.70 and a high of ₹1166.70.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.